| Price | 11.00p on 17-03-2026 at 08:33:06 |
|---|---|
| Change | 0.00p 0% |
| Buy | 11.50p |
| Sell | 10.50p |
| Last Trade: | Buy 8.00 at 11.50p |
| Day's Volume: | 8 |
| Last Close: | 11.00p |
| Open: | 11.00p |
| ISIN: | CA68234M2058 |
| Day's Range | 11.00p - 11.00p |
| 52wk Range: | 8.00p - 18.25p |
| Market Capitalisation: | £57.15m |
| VWAP: | 11.50p |
| Shares in Issue: | 519.55m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Ondine Biomed (OBI) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 8 | 11.50p | Ordinary |
08:33:04 - 17-Mar-26 |
| Buy* | 4,444 | 11.25p | Ordinary |
14:57:42 - 16-Mar-26 |
| Buy* | 17,622 | 11.35p | Ordinary |
14:45:17 - 16-Mar-26 |
| Buy* | 137 | 11.50p | Ordinary |
13:36:43 - 16-Mar-26 |
| Unknown* | 93,962 | 10.65p | Ordinary |
12:49:31 - 16-Mar-26 |
| Buy* | 312 | 11.50p | Ordinary |
12:16:38 - 16-Mar-26 |
| Buy* | 218 | 11.50p | SI Trade |
12:16:37 - 16-Mar-26 |
| Buy* | 10 | 11.50p | Ordinary |
11:29:12 - 16-Mar-26 |
| Buy* | 43,969 | 11.35p | Ordinary |
09:21:08 - 16-Mar-26 |
| Buy* | 8 | 11.50p | Ordinary |
08:35:08 - 16-Mar-26 |
Ondine Biomed (OBI) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 10th Mar 2026 7:00 am | RNS | Ondine Provides Update on US Phase 3 Pivotal Study |
| 3rd Mar 2026 7:00 am | RNS | Holdings in Company |
| 25th Feb 2026 7:00 am | RNS | Share Issuance for ICU Study Submission |
| 20th Feb 2026 5:40 pm | RNS | Holding(s) in Company |
| 6th Feb 2026 7:00 am | RNS-R | Ondine and Mid Yorks Win National Award |
| 2nd Feb 2026 7:00 am | RNS-R | Steriwave Up for 2025 “Product of the Year” Award |
| 27th Jan 2026 7:00 am | RNS-R | Expanding Steriwave Use Across Vancouver Island |
| 22nd Jan 2026 9:42 am | RNS-R | Steriwave Expands into ENT Surgery in Spain |
| 13th Jan 2026 7:00 am | RNS-R | New Independent Study Supports Photodisinfection |
| 23rd Dec 2025 7:00 am | RNS-R | Finalist for 2nd National Award for SSI reduction |
